All In MedTech

Device Trial Radar · NCT05424354

Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing

Prospective Randomized Open Label Multicenter Phase IV Clinical Trial to Compare Transforming Powder Dressing (TPD) to Current Standard of Care (SOC) Dressing Therapies in Acute Partial Thickness Burn Wounds

Last checked: Nov 20, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

May 26, 2022

Primary completion

Jun 30, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
ULURU Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Navy Advanced Medical Development (NAMD) Command
First posted
Jun 21, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.

Conditions

  • Wounds and Injuries

Interventions

  • Altrazeal (R) Transforming Powder DressingDevice

    After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with Altrazeal TPD.

  • Standard of Care burn dressingOther

    After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with the institution's standard of care burn dressing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain from the Burn WoundTime frame: 28 days (or sooner if the wound heals prior to 28 days)

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • University of California-Irvine

    Orange, California · Recruiting

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia · Recruiting

  • Jackson Memorial Hospital UM/JMH Burn Center

    Miami, Florida · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.